Tag:
RedPath
Latest Headlines
Latest Headlines
ExonHit backs out of $22.5M RedPath buyout
French cancer diagnostics company ExonHit Therapeutics has backed out of a deal to acquire Pittsburgh-based RedPath Integrated Pathology. The deal, which was first announced in April, was worth $22.5
